57
19
1
49
2
2
f
1b
1d
18
2f
82
1d
2 29
1d
25
Emily A. Blumberg
78
82
Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
28
8b
3
5f
Director, Transplant Infectious Diseases, Hospital of the University of Pennsylvania
76
Attending Physician, Hospital of the University of Pennsylvania
83
Program Director, Infectious Diseases Fellowship, University of Pennsylvania
68
Patient Safety Officer, Penn Transplant Institute
11
Department: Medicine
4
1
b
1d
46
Contact information
44
4
3
3
3
2
4
b
1f
44
3 Silverstein, Suite E
32 Hospital of the University of Pennsylvania
35 3400 Spruce Street
Philadelphia, PA 19104
26
32 Hospital of the University of Pennsylvania
35 3400 Spruce Street
Philadelphia, PA 19104
35
9f
12
13
Education:
21 9 A.B. 14 (History) c
2d Princeton University, 1977.
21 9 M.D. c
2c New York University, 1981.
c
3
3
21
21 9 A.B. 14 (History) c
2d Princeton University, 1977.
21 9 M.D. c
2c New York University, 1981.
c
1f
Post-Graduate Training
24 6a Intern in Medicine, University of Chicago Hospitals and Clinics, Chicago, IL, 1981-1982.
24 6c Resident in Medicine, University of Chicago Hospitals and Clinics, Chicago, IL, 1982-1984.
24 95 Clinical Fellow in Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, 1984-1985.
24 95 Research Fellow in Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, 1985-1987.
c
3
25
24 6a Intern in Medicine, University of Chicago Hospitals and Clinics, Chicago, IL, 1981-1982.
24 6c Resident in Medicine, University of Chicago Hospitals and Clinics, Chicago, IL, 1982-1984.
24 95 Clinical Fellow in Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, 1984-1985.
24 95 Research Fellow in Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, 1985-1987.
c
17
Certifications
28 3c American Board of Internal Medicine, 1984.
28 52 American Board of Internal Medicine (Infectious Diseases), 1986.
28 62 American Board of Internal Medicine (Infectious Diseases recertification), 2013.
c
3
8b
Permanent link28 3c American Board of Internal Medicine, 1984.
28 52 American Board of Internal Medicine (Infectious Diseases), 1986.
28 62 American Board of Internal Medicine (Infectious Diseases recertification), 2013.
c
2 29
21
1e
1d
24
5e
65
62
e 29
27
Description of Research Expertise
a5 Infections in transplant recipients, Transplantation in HIV infected patients, Antiviral therapies in transplant recipients, Donor derived infections65
Description of Clinical Expertise
33 Infections in transplant recipients62
Description of Other Expertise
21 Transplant donorse 29
23
120 Potluri VS, Schaubel DE, Blumberg EA, Morford H, Reese PP, Puttarajappa CM.: High variability in the reported prevalence of EBV-seronegative status among US kidney transplant recipients. Am J Transplant August 2025.
159 Courtwright AM, Prenner S, Doyon JB, Claridge T, Blumberg E, Bermudez CA, Crespo MM.: Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study. Transpl Infect Dis July 2025.
182 Blumberg EA, Witzke O, Harber M, Ison MG, Saliba F, Kamar N, Sundberg AK, Gu J, Kumar D, La Hoz RM.: Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study. J Heart Lung Transplant June 2025.
236 Freercks R, Rodrigues M, Manning K, Heymann J, Kopp JB, Nagiah S, Rana M, Florman S, Friedman-Moraco R, Stock P, Gilbert A, Mehta S, Stosor V, Pereira MR, Morris MI, Hand J, Haidar G, Malinis M, Santos CAQ, Schaenman J, Blumberg EA, Wojciechowski D, Odim J, Massie A, Selvan MT, Bagnasco S, Segev D, Tobian AA, Muller E, Durand CM, Redd AD.: APOL1 genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIV. medRxiv Apr 2025.
21c Potluri VS, Goldberg D, Zhang S, Schaubel DE, Molnar MZ, Forbes R, Sise ME, Rogers JL, Balaraman V, Bhalla A, Shaffer D, Concepcion BP, Chung RT, Strohbehn IA, Mapchan S, Vujjini V, Sangadi A, Martin E, Bloom RD, Ammazzalorso A, Blumberg EA, Reese PP.: Risk of cytomegalovirus viremia following transplantation of Hepatitis C-viremic donor kidneys into uninfected recipients: A multi-center retrospective cohort study. Transplant Infect Dis. 27: e70011, March 2025.
1c7 Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM.: The association of Epstein-Barr virus donor and recipient serostatus with outcomes after kidney transplantation: A retrospective cohort study. Ann Intern Med Annals of Internal Medicine 178: 157-166. January 2025.
118 He KD, Nguyen L, Norris M, Malat G, Witek S, Sammons C, Forte A, Claridge T, Clark JT, Blumberg E.: Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants. Transpl Infect Dis January 2025.
138 Greenwald MA, Ezzeldin H, Blumberg EA, Whitaker BI, Forshee RA: Real-world data to improve organ and tissue donation policies: lessons learned from the tissue and organ donation epidemiology study. Health Res Policy Syst 22, November 2024.
161 Moore K, Lautenbach E, Blumberg EA, Han J, Lee DH, Clauss H, Hasz R, Bilker WB, Molnar E, Alimenti D, West S, Tolomeo P, Anesi JA.: Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomes. Am J Transplant August 2024.
2c
7
1d
1f
Selected Publications
14f Knox JJ, Lee I, Blumberg EA, Rosenfeld AM, Meng W, Liu F, Kearns C, O'Doherty U, Shaked A, Olthoff KM, Luning Prak ET.: B-Cell Subset Representation Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients. J Infect Dis 232: e466-e475, Sep 2025.120 Potluri VS, Schaubel DE, Blumberg EA, Morford H, Reese PP, Puttarajappa CM.: High variability in the reported prevalence of EBV-seronegative status among US kidney transplant recipients. Am J Transplant August 2025.
159 Courtwright AM, Prenner S, Doyon JB, Claridge T, Blumberg E, Bermudez CA, Crespo MM.: Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study. Transpl Infect Dis July 2025.
182 Blumberg EA, Witzke O, Harber M, Ison MG, Saliba F, Kamar N, Sundberg AK, Gu J, Kumar D, La Hoz RM.: Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study. J Heart Lung Transplant June 2025.
236 Freercks R, Rodrigues M, Manning K, Heymann J, Kopp JB, Nagiah S, Rana M, Florman S, Friedman-Moraco R, Stock P, Gilbert A, Mehta S, Stosor V, Pereira MR, Morris MI, Hand J, Haidar G, Malinis M, Santos CAQ, Schaenman J, Blumberg EA, Wojciechowski D, Odim J, Massie A, Selvan MT, Bagnasco S, Segev D, Tobian AA, Muller E, Durand CM, Redd AD.: APOL1 genotype and patient outcomes in US and South African transplant recipients with HIV who received kidneys from donors with HIV. medRxiv Apr 2025.
21c Potluri VS, Goldberg D, Zhang S, Schaubel DE, Molnar MZ, Forbes R, Sise ME, Rogers JL, Balaraman V, Bhalla A, Shaffer D, Concepcion BP, Chung RT, Strohbehn IA, Mapchan S, Vujjini V, Sangadi A, Martin E, Bloom RD, Ammazzalorso A, Blumberg EA, Reese PP.: Risk of cytomegalovirus viremia following transplantation of Hepatitis C-viremic donor kidneys into uninfected recipients: A multi-center retrospective cohort study. Transplant Infect Dis. 27: e70011, March 2025.
1c7 Potluri VS, Zhang S, Schaubel DE, Shaikhouni S, Blumberg EA, Nasta SD, Bloom RD, Cruz-Peralta M, Mehta RB, Lavu NR, Getachew B, Tandukar S, Reese PP, Puttarajappa CM.: The association of Epstein-Barr virus donor and recipient serostatus with outcomes after kidney transplantation: A retrospective cohort study. Ann Intern Med Annals of Internal Medicine 178: 157-166. January 2025.
118 He KD, Nguyen L, Norris M, Malat G, Witek S, Sammons C, Forte A, Claridge T, Clark JT, Blumberg E.: Alternative Pneumocystis Pneumonia Prophylaxis in Solid Organ Transplants. Transpl Infect Dis January 2025.
138 Greenwald MA, Ezzeldin H, Blumberg EA, Whitaker BI, Forshee RA: Real-world data to improve organ and tissue donation policies: lessons learned from the tissue and organ donation epidemiology study. Health Res Policy Syst 22, November 2024.
161 Moore K, Lautenbach E, Blumberg EA, Han J, Lee DH, Clauss H, Hasz R, Bilker WB, Molnar E, Alimenti D, West S, Tolomeo P, Anesi JA.: Impact of deceased organ donor marijuana use on donor culture positivity and solid organ transplant recipient outcomes. Am J Transplant August 2024.
2c